Satoshi Ikeo

980 total citations
22 papers, 679 citations indexed

About

Satoshi Ikeo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Satoshi Ikeo has authored 22 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 4 papers in Rheumatology. Recurrent topics in Satoshi Ikeo's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Pluripotent Stem Cells Research (2 papers). Satoshi Ikeo is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Pluripotent Stem Cells Research (2 papers). Satoshi Ikeo collaborates with scholars based in Japan, United Kingdom and United States. Satoshi Ikeo's co-authors include Tim Hunt, Julian Gannon, Satoru Mochida, Naoyuki Sone, Shimpei Gotoh, Toyohiro Hirai, Yuki Yamamoto, Y. Korogi, Satoshi Konishi and Hisako Matsumoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Biomaterials.

In The Last Decade

Satoshi Ikeo

20 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Ikeo Japan 8 363 266 199 122 106 22 679
Nobuhiro Yamakawa Japan 14 263 0.7× 137 0.5× 39 0.2× 134 1.1× 183 1.7× 57 647
Konstantin I. Izvolsky United States 11 701 1.9× 533 2.0× 143 0.7× 357 2.9× 53 0.5× 14 1.0k
Akira Joraku Japan 15 184 0.5× 103 0.4× 35 0.2× 287 2.4× 106 1.0× 37 705
Chaitra Cheluvaraju United States 4 176 0.5× 268 1.0× 43 0.2× 62 0.5× 66 0.6× 7 486
Annie Renier France 19 158 0.4× 760 2.9× 80 0.4× 49 0.4× 217 2.0× 36 1.1k
Jinwook Choi South Korea 11 357 1.0× 440 1.7× 37 0.2× 220 1.8× 104 1.0× 17 831
Susan Jennings United States 10 611 1.7× 300 1.1× 74 0.4× 111 0.9× 50 0.5× 11 914
Maiko Kondo Japan 13 522 1.4× 104 0.4× 44 0.2× 251 2.1× 63 0.6× 33 858
John Panelos Italy 10 160 0.4× 123 0.5× 33 0.2× 39 0.3× 218 2.1× 18 487
Huan Tran United States 10 213 0.6× 53 0.2× 82 0.4× 38 0.3× 51 0.5× 14 463

Countries citing papers authored by Satoshi Ikeo

Since Specialization
Citations

This map shows the geographic impact of Satoshi Ikeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Ikeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Ikeo more than expected).

Fields of papers citing papers by Satoshi Ikeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Ikeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Ikeo. The network helps show where Satoshi Ikeo may publish in the future.

Co-authorship network of co-authors of Satoshi Ikeo

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Ikeo. A scholar is included among the top collaborators of Satoshi Ikeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Ikeo. Satoshi Ikeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwata, Toshiyuki, et al.. (2024). Unilateral acute respiratory distress syndrome appearing contralateral to lung cancer. Respiratory Medicine Case Reports. 51. 102093–102093.
2.
Nogami, Naoyuki, Toshio Kubo, Akihiro Bessho, et al.. (2024). A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL). Japanese Journal of Clinical Oncology. 54(7). 805–812. 1 indexed citations
3.
4.
Ikeo, Satoshi, et al.. (2023). Transient asymptomatic pulmonary opacities in a patient with MET exon 14 skipping non‐small cell lung cancer: A case report. Thoracic Cancer. 14(10). 958–960. 3 indexed citations
5.
Ikeo, Satoshi, et al.. (2023). Physiologic 18F‐FDG muscle uptake in severe COPD: Implications for accurate lung cancer staging. SHILAP Revista de lepidopterología. 11(5). e01150–e01150. 1 indexed citations
6.
Ikeo, Satoshi, et al.. (2023). Concurrent trastuzumab deruxtecan-induced interstitial lung disease and COVID-19 in the treatment of advanced breast cancer. Oxford Medical Case Reports. 2023(12). omad135–omad135. 1 indexed citations
7.
Ikeo, Satoshi, et al.. (2022). Negative pressure pulmonary edema in a patient with COVID‐19. SHILAP Revista de lepidopterología. 10(12). e01062–e01062. 2 indexed citations
8.
Ikeo, Satoshi, et al.. (2022). Epipericardial fat necrosis in a patient with sudden chest pain. SHILAP Revista de lepidopterología. 10(12). e01068–e01068. 1 indexed citations
9.
Sone, Naoyuki, Satoshi Konishi, Koichi Igura, et al.. (2021). Multicellular modeling of ciliopathy by combining iPS cells and microfluidic airway-on-a-chip technology. Science Translational Medicine. 13(601). 41 indexed citations
10.
Ikeo, Satoshi, Yuki Yamamoto, Kazuhiro Ikeda, et al.. (2021). Core-shell hydrogel microfiber-expanded pluripotent stem cell-derived lung progenitors applicable to lung reconstruction in vivo. Biomaterials. 276. 121031–121031. 14 indexed citations
11.
Ikeo, Satoshi, Yuki Yamamoto, Masahide Seki, et al.. (2020). Directed induction of alveolar type I cells derived from pluripotent stem cells via Wnt signaling inhibition. Stem Cells. 39(2). 156–169. 38 indexed citations
12.
Korogi, Y., Shimpei Gotoh, Satoshi Ikeo, et al.. (2019). In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids. Stem Cell Reports. 12(3). 431–440. 70 indexed citations
13.
Kubo, Toshio, Naoyuki Nogami, Akihiro Bessho, et al.. (2019). Phase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402). Annals of Oncology. 30. ix172–ix173. 1 indexed citations
14.
Ikeda, Satoshi, Hiroshige Yoshioka, Satoshi Ikeo, et al.. (2017). Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status. BMC Cancer. 17(1). 797–797. 49 indexed citations
15.
Yamamoto, Yuki, Shimpei Gotoh, Y. Korogi, et al.. (2017). Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. Nature Methods. 14(11). 1097–1106. 180 indexed citations
16.
Ikeda, Satoshi, Machiko Arita, Mitsunori Morita, et al.. (2015). Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?. BMC Pulmonary Medicine. 15(1). 159–159. 39 indexed citations
17.
Nishiyama, Akihiro, Hiroshige Yoshioka, Satoshi Ikeo, et al.. (2015). Retroperitoneal Metastasis from Lung Adenocarcinoma Mimics Retroperitoneal Fibrosis. Journal of Thoracic Oncology. 11(2). 266–267. 2 indexed citations
18.
Furuta, Kenjiro, Satoshi Ikeo, Satoshi Ikeda, et al.. (2015). Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglobinemia. Internal Medicine. 54(13). 1639–1641. 4 indexed citations
19.
20.
Mochida, Satoru, Satoshi Ikeo, Julian Gannon, & Tim Hunt. (2009). Regulated activity of PP2A–B55δ is crucial for controlling entry into and exit from mitosis in Xenopus egg extracts. The EMBO Journal. 28(18). 2777–2785. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuhiro Yamakawa Breakdown of academic impact, for papers by Konstantin I. Izvolsky Breakdown of academic impact, for papers by Akira Joraku Breakdown of academic impact, for papers by Chaitra Cheluvaraju Breakdown of academic impact, for papers by Annie Renier Breakdown of academic impact, for papers by Jinwook Choi Breakdown of academic impact, for papers by Susan Jennings Breakdown of academic impact, for papers by Maiko Kondo Breakdown of academic impact, for papers by John Panelos Breakdown of academic impact, for papers by Huan Tran
Rankless by CCL
2026